Application Nr Approved Date Route Status External Links
NDA018771 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Lacrisert Is Indicated In Patients With Moderate To Severe Dry Eye Syndromes, Including Keratoconjunctivitis Sicca. Lacrisert Is Indicated Especially In Patients Who Remain Symptomatic After An Adequate Trial Of Therapy With Artificial Tear Solutions. Lacrisert Is Also Indicated For Patients With: Exposure Keratitis Decreased Corneal Sensitivity Recurrent Corneal Erosions

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Hydroxypropyl Cellulose (1600000 Wamw)

Comments